The Resurgence and Clinical Development of Influenza A in Pediatric Populations in China: Changes in Epidemiology and Serological Patterns from Pre-Pandemic to Post-Pandemic Periods (2019–2023) - Scorecard - MDSpire

The Resurgence and Clinical Development of Influenza A in Pediatric Populations in China: Changes in Epidemiology and Serological Patterns from Pre-Pandemic to Post-Pandemic Periods (2019–2023)

  • By

  • Guiling Xu

  • Yu Chen

  • Yu Zhu

  • Qing Fang

  • Xiaotong Xue

  • Kejun Hu

  • Sha Zhou

  • Li Hong

  • Ying Xiang

  • January 17, 2026

  • 0 min

Share

Clinical Scorecard: The Resurgence and Clinical Development of Influenza A in Pediatric Populations in China: Changes in Epidemiology and Serological Patterns from Pre-Pandemic to Post-Pandemic Periods (2019–2023)

At a Glance

CategoryDetail
Condition
Key MechanismsRespiratory transmission, seasonal epidemics, immune debt due to pandemic-related disruptions, impact of NPIs.
Target Population
Care Setting

Key Highlights

  • vaccination_rates

Guideline-Based Recommendations

Diagnosis

    Management

    • I
    • n
    • c
    • l
    • u
    • d
    • e
    • s
    • p
    • e
    • c
    • i
    • f
    • i
    • c
    • a
    • n
    • t
    • i
    • v
    • i
    • r
    • a
    • l
    • t
    • r
    • e
    • a
    • t
    • m
    • e
    • n
    • t
    • s
    • f
    • o
    • r
    • p
    • e
    • d
    • i
    • a
    • t
    • r
    • i
    • c
    • p
    • a
    • t
    • i
    • e
    • n
    • t
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Pediatric patients aged 0-18 years tested for influenza A

        Clinical management should focus on vaccination and monitoring for severe cases.

        Clinical Best Practices

        • additions

        Related Resources & Content

        Original Source(s)

        Related Content